Literature DB >> 1584205

Regulation of the expression of lactate dehydrogenase isozymes in human lymphocytes.

P Wollberg1, B D Nelson.   

Abstract

Mitogen activation of human peripheral lymphocytes leads to a switch in the isozymes of LDH; resting cells contain low activities of only the B4 and B3A forms, whereas activated cells contain high activities of the A4 and A3B forms. B4 LDH is not altered in activated cells. In this study we show that the appearance of the A subunits occurs concomitantly with a several fold increase in the steady state levels of LDH-A mRNA. Responses in LDH-A mRNA are observed within 12 hrs of activation, and are, thus, associated with the G0/G1 transition or with early G1 (Marjanovic et al. Exp. Cell Res. (1991) 193: 425-431). Maximal expression of LDH-A mRNA requires both phorbol ester and concanavalin A, implying a complex regulatory pathway involving cascade systems activated through both the antigen receptor (TR) and protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584205     DOI: 10.1007/bf02454193

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  Lactate dehydrogenase isoenzyme pattern as a measure of cellular differentiation in lymphocytic cells.

Authors:  J Plum; S Ringoir
Journal:  J Reticuloendothel Soc       Date:  1977-04

2.  RNA isolation: a mini-prep method.

Authors:  M Wilkinson
Journal:  Nucleic Acids Res       Date:  1988-11-25       Impact factor: 16.971

3.  Changes in the activity and isozyme patterns of glycolytic enzymes during stimulation of normal human lymphocytes with phytohaemagglutinin.

Authors:  P A Rogers; D P Brenton; D A Hopkinson
Journal:  Ann Hum Genet       Date:  1980-01       Impact factor: 1.670

4.  cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1.

Authors:  K W Johnson; B H Davis; K A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1.

Authors:  H K Blomhoff; R Blomhoff; T Stokke; C deLange Davies; K Brevik; E B Smeland; S Funderud; T Godal
Journal:  J Cell Physiol       Date:  1988-12       Impact factor: 6.384

6.  cDNA cloning and characterization of interleukin 2-induced genes in a cloned T helper lymphocyte.

Authors:  D E Sabath; P L Podolin; P G Comber; M B Prystowsky
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

7.  Identification of rat ovarian nuclear factors that interact with the cAMP-inducible lactate dehydrogenase A subunit promoter.

Authors:  J Kwast-Welfeld; C J Soong; M L Short; R A Jungmann
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

8.  Effect of phorbol myristate acetate and concanavalin A on the glycolytic enzymes of human peripheral lymphocytes.

Authors:  S Marjanovic; A Wielburski; B D Nelson
Journal:  Biochim Biophys Acta       Date:  1988-06-08

9.  Isoenzyme studies in human leukemia-lymphoma cell lines--IV. Lactate dehydrogenase.

Authors:  H G Drexler; G Gaedicke; J Minowada
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

10.  Cyclic AMP regulation of lactate dehydrogenase. Isoproterenol and N6,O2-dibutyryl cyclic amp increase the rate of transcription and change the stability of lactate dehydrogenase a subunit messenger RNA in rat C6 glioma cells.

Authors:  R A Jungmann; D C Kelley; M F Miles; D M Milkowski
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

View more
  2 in total

Review 1.  Investigation of NK cell function and their modulation in different malignancies.

Authors:  Gordana Konjevic; Vladimir Jurisic; Viktor Jovic; Ana Vuletic; Katarina Mirjacic Martinovic; Sandra Radenkovic; Ivan Spuzic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  The comparison of spontaneous LDH release activity from cultured PBMC with sera LDH activity in non-Hodgkin's lymphoma patients.

Authors:  V Jurisić; G Konjević; R Jancić-Nedeljkov; M Sretenović; B Banicević; M Colović; I Spuzić
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.